Clinical Decision Support for Opioid Addiction

Not yet recruiting at 2 trial locations
EM
LB
Overseen ByLaurel Buchanan, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is stage 2, round 3 of a larger study which refines and optimizes the EMBED clinical decision support (CDS) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. See NCT03658642

Who Is on the Research Team?

EM

Edward Mel, MD, MHS

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for emergency department doctors who treat patients with opioid use disorder. It focuses on improving how these doctors follow guidelines when giving buprenorphine to people struggling with opioid addiction.

Inclusion Criteria

Emergency department patient
Moderate to severe opioid use disorder
I am 18 years old or older.

Exclusion Criteria

Pregnant
I am under 18 years old.
I am currently taking medication for opioid use disorder.

What Are the Treatments Tested in This Trial?

Trial Overview

The study is testing a refined clinical decision support tool (EMBED CDS) and provider alerts about nurse assessments, aiming to help doctors better manage care for opioid addiction in the ER. The design involves comparing different versions of these tools.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Refined EMBED plus provider alert the nurse completed COWSExperimental Treatment1 Intervention
Group II: Refined EMBED CDSActive Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+